Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,044 | 6 | 41.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,213 | 8 | 29.3% |
| Food and Beverage | $6,861 | 217 | 21.8% |
| Travel and Lodging | $2,103 | 11 | 6.7% |
| Education | $230.84 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $13,546 | 43 | $0 (2024) |
| Eli Lilly and Company | $8,543 | 5 | $0 (2024) |
| PFIZER INC. | $3,481 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $831.71 | 14 | $0 (2024) |
| Novo Nordisk Inc | $827.00 | 34 | $0 (2024) |
| Amgen Inc. | $520.37 | 10 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $442.04 | 11 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $387.42 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $270.18 | 7 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $268.89 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,632 | 56 | Eli Lilly and Company ($6,293) |
| 2023 | $7,074 | 80 | Lilly USA, LLC ($5,645) |
| 2022 | $4,612 | 46 | Lilly USA, LLC ($1,557) |
| 2021 | $9,133 | 64 | Lilly USA, LLC ($6,293) |
All Payment Transactions
246 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Oncology | ||||||
| 11/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: VACCINES | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| Category: Cardiovascular | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 10/30/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.88 | General |
| Category: NEUROLOGY | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $64.70 | General |
| Category: DIABETES | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $103.45 | General |
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | Eli Lilly and Company | KISUNLA (Drug) | Consulting Fee | Cash or cash equivalent | $4,218.75 | General |
| Category: Neuroscience | ||||||
| 08/16/2024 | Eli Lilly and Company | KISUNLA (Drug) | Consulting Fee | Cash or cash equivalent | $1,325.00 | General |
| Category: Neuroscience | ||||||
| 08/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $749.73 | General |
| 07/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Inflammation | ||||||
| 07/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: VACCINES | ||||||
| 07/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.61 | General |
| Category: Cardiovascular | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Respiratory | ||||||
| 06/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $106.11 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 421 | 657 | $113,662 | $33,870 |
| 2022 | 17 | 655 | 985 | $167,944 | $57,240 |
| 2021 | 15 | 573 | 913 | $156,079 | $51,051 |
| 2020 | 11 | 455 | 632 | $89,550 | $25,496 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 169 | 339 | $71,720 | $19,680 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $24,795 | $8,880 | 35.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 57 | $8,151 | $2,967 | 36.4% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 37 | 42 | $2,688 | $1,318 | 49.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 57 | $3,705 | $515.16 | 13.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 20 | 20 | $920.00 | $288.80 | 31.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 11 | 33 | $1,155 | $138.60 | 12.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 18 | 22 | $528.00 | $82.74 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 419 | $88,828 | $28,183 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 119 | 119 | $33,915 | $12,340 | 36.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $8,079 | $3,615 | 44.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 56 | $8,008 | $2,790 | 34.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $4,378 | $1,984 | 45.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $2,498 | $1,450 | 58.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,661 | $1,264 | 22.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 46 | $1,610 | $1,213 | 75.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 14 | 14 | $2,106 | $983.50 | 46.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 26 | 29 | $1,856 | $851.13 | 45.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 28 | 28 | $980.00 | $730.72 | 74.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 37 | 72 | $4,680 | $689.73 | 14.7% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 16 | 16 | $640.00 | $570.24 | 89.1% |
| 85610 | Blood test, clotting time | Office | 2022 | 13 | 44 | $1,540 | $186.58 | 12.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 12 | 31 | $1,333 | $181.54 | 13.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 16 | $1,280 | $117.51 | 9.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 19 | 23 | $552.00 | $91.06 | 16.5% |
About Laurie Garner, PAC
Laurie Garner, PAC is a Physician Assistant healthcare provider based in Versailles, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598766701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Laurie Garner, PAC has received a total of $31,451 in payments from pharmaceutical and medical device companies, with $10,632 received in 2024. These payments were reported across 246 transactions from 42 companies. The most common payment nature is "Consulting Fee" ($13,044).
As a Medicare-enrolled provider, Garner has provided services to 2,104 Medicare beneficiaries, totaling 3,187 services with total Medicare billing of $167,657. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Versailles, KY
- Active Since 08/10/2005
- Last Updated 07/30/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1598766701
Products in Payments
- EMGALITY (Drug) $6,295
- KISUNLA (Drug) $5,544
- ZAVZPRET (Drug) $3,025
- NURTEC ODT (Drug) $686.17
- Ozempic (Drug) $407.99
- Kerendia (Drug) $387.42
- FARXIGA (Drug) $360.73
- BREZTRI (Drug) $353.38
- Aimovig (Biological) $325.53
- JARDIANCE (Drug) $242.75
- UBRELVY (Drug) $221.39
- NEXLIZET (Drug) $207.47
- Rybelsus (Drug) $161.79
- XARELTO (Drug) $157.90
- VOQUEZNA (Drug) $127.15
- QUVIVIQ (Drug) $125.00
- Saxenda (Drug) $124.99
- MOUNJARO (Drug) $122.28
- Repatha (Biological) $120.90
- ELIQUIS (Drug) $114.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Versailles
Claire Schack, Pa, PA
Physician Assistant — Payments: $4,718
Mrs. Kristi Hall, Pac, PAC
Physician Assistant — Payments: $23.51
Katherine Bollinger, Pa-C, PA-C
Physician Assistant
Cole Condon, Pa-S, PA-S
Physician Assistant